Rules and Regulations. Notice of intent

Agency: Department of Veterans Affairs, Office of Research and Development
Action: Notice of intent
Citation: FR Doc. 2012-4885

Summary

Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to Somahlution, Inc., 3401 Fiechtner Drive, Fargo, North Dakota 58103, USA, an exclusive license to practice the following: U.S. Patent No. 7,981,596 (Tissue preservation with a salt solution isotonic with interstitial fluid) issued July 19, 2011.

Dates

Comments must be received March 16, 2012.

Supplementary Information

It is in the public interest to so license these inventions, as Somahlution, Inc., submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Dated: February 23, 2012. John R. Gingrich, Chief of Staff, Department of Veterans Affairs. [FR Doc. 2012-4885 Filed 2-29-12; 8:45 am]